← Back to All Filings
Jazz Pharmaceuticals EVP & Chief Legal Officer Sells $289K in Ordinary Shares Under 10b5-1 Plan
Jazz Pharmaceuticals plc
$JAZZ4CIK: 0001232524
Subscribe to track JAZZ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Insider Sale Notification: Jazz Pharmaceuticals plc ($JAZZ) Insider: Neena M Patil (EVP & Chief Legal Officer) Transaction Date: September 10, 2026 Type: Sale (Code: S | Rule 10b5-1 Plan) Shares Transacted: 1,200 @ $240.94 Total Value: $289,128.00 Shares Held Following Transaction: 47,671 Direct/Indirect: Direct
Comprehensive Analysis
Insider Transaction Summary
- Company: Jazz Pharmaceuticals plc ($JAZZ)
- Insider: Neena M Patil, EVP & Chief Legal Officer
- Transaction: Sale of 1,200 Ordinary Shares at an average price of $240.94 per share on September 10, 2026, totaling approximately $289,128.00.
- Post-Transaction Holdings: Direct ownership of 47,671 Ordinary Shares.
Context & Significance
- Trading Plan: The disposition was executed automatically pursuant to a pre-arranged Rule 10b5-1 trading plan established on February 26, 2026.
- Significance Assessment: Low. The transaction constitutes a small portion (approx. 2.5%) of the insider's total equity holdings and was executed under a non-discretionary 10b5-1 trading plan.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.